Clinical Trials Browser

Recruiting × Observational × Pluvicto × Clear all

NCT06389097 2026-03-30

(SEEtoTREAT)

Prostatic Neoplasms

NCT06514521 2025-12-30

Post Marketing Study on Pluvicto in Korea

Metastatic Castration-resistant Prostate Cancer